Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vivus: into single digits -- Ignore unavailable to you. Want to Upgrade?

To: MIKE DUBIS who wrote (415)	5/2/1998 12:34:00 AM
From: 777 Captain	Read Replies (1) \| Respond to of 1016

I think we may have traded in the single digits after today's close. So what are you waiting for? Even though I'm long VVUS, I found a lot of the information (by no means all) posted on this thread useful & informative. The party is by no means over yet for VVUS - long or short. So let the good times roll!!! Regards.

To: MIKE DUBIS who wrote (415)	5/4/1998 12:00:00 PM
From: MIKE DUBIS	Read Replies (2) \| Respond to of 1016

Script numbers for PFE NEW YORK, May 4 (Reuters) - New U.S. prescriptions for Pfizer Inc. impotence drug Viagra leaped to 207,868 in the week ending April 24, its third week on the market -- eclipsing its stellar performance during prior weeks, PaineWebber analyst Jeff Chaffkin told Reuters. Chaffkin said data obtained by him from auditing firm IMS America showed sales of Viagra continued to grow apace, easily outstripping the 113,134 new prescriptions written for the first impotence pill during the prior week ending April 17. "It's just a tremendous number," Chaffkin said of the third-week results.